Letter Sequence Approval |
|---|
|
Results
Other: ML20338A160, ML20338A165, ML21026A001, ML21055A810, ML21055A820, ML21110A147, ML21110A148, ML21159A143, ML21187A126, ML21204A101, ML21309A105, ML22109A121, ML22200A061, ML22259A001, ML24040A176, ML24040A179, ML24044A062, ML24044A063
|
MONTHYEARML19221B7422019-08-30030 August 2019 Proprietary Determination Letter for ANP-10337, Revision 0, Supplement 1P, Revision 0, Deformable Spacer Grid Element RAI Response Project stage: RAI ML19347C1932019-12-10010 December 2019 Email Transmittal of Request for Additional Information Questions Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: RAI ML20083K3862020-03-26026 March 2020 Round 1 Request for Additional Information Questions for the Review of Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Non-Proprietary) Project stage: RAI ML20338A1652020-12-10010 December 2020 Regulatory Audit Plan for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 Project stage: Other ML20338A1602020-12-10010 December 2020 December 7 - 11, 2020, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21026A0012021-02-0909 February 2021 Audit Report Letter for Framatome Topical Report ANP-10229P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21055A8102021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021 Regulatory Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project No. 728 EPID L-2018-TOP-0034 Project stage: Other ML21055A8202021-03-0101 March 2021 March 3, 4, 24, 25, and 26, 2021, Regulatory Audit Plan Letter for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21110A1472021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L-2018-TOP-0034) (Letter) Project stage: Other ML21110A1482021-05-0404 May 2021 April 22, 2021, Audit Plan for Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21159A1432021-06-11011 June 2021 June 15, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21187A1262021-07-0909 July 2021 July 9, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML21204A1012021-07-27027 July 2021 August 11-12, 2021, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - ARTEMIS-RELAP Integrated Transient Analysis Methodology Project stage: Other ML21309A1052021-11-0808 November 2021 November 8, 2021 Audit Plan for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22109A1212022-04-22022 April 2022 April 20 - 21, and 28, 2022, Regulatory Audit Plan for Framatome Inc. Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22097A2642022-04-26026 April 2022 U.S. Nuclear Regulatory Commissions Revised Schedule for Review of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML22200A0612022-07-25025 July 2022 Report for 2021 - 2022, Regulatory Audits Regarding Framatome Inc. Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22259A0012022-10-0505 October 2022 Schedule Change Letter for Framatome Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML22357A0822023-01-0909 January 2023 The U.S. Nuclear Regulatory Commissions Revised Schedule for the Review of Framatome’S Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Approval ML23006A2522023-01-17017 January 2023 Summary of Closed Hybrid Meeting with Framatome Inc. and the U. S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230079, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-01-30030 January 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23072A3862023-04-0606 April 2023 Summary of March 2, 3023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, ANP-10339P, Revision 0, ARITA-ARTEMIS/RELAP Integrated Transient Analysis Methodology Project stage: Meeting PMNS20230725, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-06-0909 June 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23177A2582023-07-10010 July 2023 Summary of June 20, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report, Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting PMNS20231147, Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology2023-10-0606 October 2023 Closed Meeting with the Nuclear Regulatory Commission and Framatome Regarding Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Request ML23233A1392023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report Anp 10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (EPID L 2018-TOP-0034) Letter Project stage: Approval ML23299A2402023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology (Appendix IV) - Non-Proprietary Project stage: Approval ML23299A2322023-10-16016 October 2023 Final Safety Evaluation for Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology - Non-Proprietary Project stage: Approval ML23305A0642023-11-0505 November 2023 Summary of October 19, 2023, Closed Meeting with Framatome Inc. and the U.S. Nuclear Regulatory Commission for Topical Report ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Meeting ML24044A0632024-02-13013 February 2024 Transmittal Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24044A0622024-02-13013 February 2024 Withholding Determination for Publication of Framatome Topical Report, ANP-10339P, Rev. 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Project stage: Other ML24040A1792024-04-16016 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Topical Report Project stage: Other ML24040A1762024-04-22022 April 2024 Verification for Publication of Framatome Topical Report, ANP-10339P, Revision 0, Arita - Artemis/Relap Integrated Transient Analysis Methodology Transmittal (EPID L-2018-TOP-0034) - Email Project stage: Other 2022-04-26
[Table View] |
Text
April 26, 2022 Mr. Gary Peters, Director Licensing and Regulatory Affairs Framatome Inc.
3315 Old Forest Road Lynchburg, VA 24501
SUBJECT:
THE U.S. NUCLEAR REGULATORY COMMISSIONS REVISED SCHEDULE FOR THE REVIEW OF FRAMATOMES TOPICAL REPORT, ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY (EPID L-2018-TOP-0034)
Dear Mr. Peters:
The U.S. Nuclear Regulatory Commission (NRC) staff plans to revise the schedule for its review of Framatome, Inc. (Framatome) Topical Report (TR) ANP-10339P, Revision 0, ARITA -
ARTEMIS/RELAP Integrated Transient Analysis Methodology (Agencywide Documents Access and Management System (ADAMS) Package Accession No. ML18242A480), submitted on August 28, 2018. By letter dated December 18, 2018 (ADAMS Accession No. ML18345A159),
the NRC staff established an initial TR review schedule with NRC milestone dates for the requests for additional information (RAIs) by November 15, 2019, and issuance of the final safety evaluation (SE) by August 31, 2021.
The initial schedule provided in the December 18, 2018, letter, considered that Framatome would provide the requested technical information in sufficient detail to enable the NRC staff to begin its detailed technical review. On March 14, 2019 (ADAMS Accession No. ML19078A260),
Framatome provided supplemental information to the December 18, 2018, letter. During the detailed review, the NRC staff issued 92 RAIs between December 2019 and April 2020. The responses to the NRC staffs RAIs were submitted on March 31, 2020 (ADAMS Package Accession No. ML20097E582), July 31, 2020 (ADAMS Package Accession No. ML20237F488),
November 20, 2020 (ADAMS Package Accession No. ML20335A217), and June 2, 2021 (ADAMS Package Accession No. ML21162A080).
In February 2021, the NRC transmittal date for the final SE was revised from August 31, 2021, to December 31, 2021, because some of the RAI responses were delayed and the NRC staff needed additional time to conduct several audits regarding the RAI responses. In August 2021, the schedule was revised again because the review progress was not in line with the schedule at that time, even though there were frequent interactions between the NRC staff and Framatome representatives during audits and meetings. Subsequently, the draft and final SE dates were revised to February 25, 2022, and May 31, 2022, respectively.
The NRC drop-in meetings were held between NRC and Framatome management on October 21, 2021, and February 23, 2022, to discuss the schedule and review progress. At the drop-in meeting on October 21, 2021, the NRC and Framatome management discussed options to either continue RAI discussions during audits and public meetings or end such discussions and focus on completing the draft SE. It was noted at the time that ending the RAI discussions may have resulted in a significant number of limitations and conditions in the NRC staffs final SE.
As a result of the drop-in meetings, it was determined that the path forward for the review would be to continue discussions on the unresolved RAIs. Currently, the NRC staff and Framatome representatives plan to finish the RAI discussions by the end of April 2022.
This revised schedule provides a new baseline for the ARITA TR review. The NRC staff plans to issue the draft SE by October 14, 2022, and final SE by February 28, 2023, as annotated in the enclosed revised schedule. This revised schedule is based on Framatome providing all final submittals by May 31, 2022. Additionally, it is based on the Advisory Committee on Reactor Safeguards subcommittee and full committee meetings will be held as scheduled on December 12, 2022, and February 2, 2023, respectively.
If you have any questions regarding the TR review, please contact me at 301-415-6695 or via email at Ngola.Otto@nrc.gov.
Sincerely,
/RA/
Ngola A. Otto, Project Manager Licensing Projects Branch Division of Operating Reactor Licensing Office of Nuclear Reactor Regulation Docket No.: 99902041
Enclosure:
As stated
Enclosure U.S. Nuclear Regulatory Commission Revised Review Schedule for the Framatome, Inc.
Topical Report ANP-10339P, Revision 0, ARITA - ARTEMIS/RELAP Integrated Transient Analysis Methodology Docket No. 99902041 EPID L-2018-TOP-0034 Milestone Revised Date Complete Request for Additional Information (RAI) Discussions April 29, 2022 Framatome Inc. (Framatome) Final Transmittal of RAIs and Topical Report Updates May 31, 2022 U.S. Nuclear Regulatory Commission (NRC)
Issues Draft Safety Evaluation (SE)
October 14, 2022 Framatome Proprietary Review of Draft SE November 6, 2022 Advisory Committee on Reactor Safeguards (ACRS) Subcommittee Meeting December 12, 2022 ACRS Full Committee Meeting February 2, 2023 NRC Issues Final SE February 28, 2023
SUBJECT:
THE U.S. NUCLEAR REGULATORY COMMISSIONS REVISED SCHEDULE FOR THE REVIEW OF FRAMATOMES TOPICAL REPORT, ANP-10339P, REVISION 0, ARITA - ARTEMIS/RELAP INTEGRATED TRANSIENT ANALYSIS METHODOLOGY (EPID L-2018-TOP-0034)
DATED: APRIL 26, 2022 DISTRIBUTION:
PUBLIC RidsACRS_MailCTR Resource RidsNrrLADHarrison Resource RidsOgcMailCenter Resource RidsNrrDorlOd Resource RidsNrrDssSfnb Resource RidsNrrDorlLlpb Resource RidsResOd Resource RidsNrrDss Resource KHeller, NRR JLehning, NRR JKaizer, NRR RChang, NRR RLukes, NRR NOtto, NRR JDonoghue, NRR MJRoss-Lee, NRR GSuber, NRR BPham, NRR ADAMS Accession Number: ML22097A264
- via email OFFICE NRR/DORL/LLPB/PM* NRR/DORL/LLPB/LA* NRR/DSS/SFNB/BC*
NRR/DORL/LLPB/BC*
NAME NOtto DHarrison RLukes RChang (LFields for)
DATE 04/11/2022 04/13/2022 04/13/2022 04/13/2022 OFFICE NRR/DORL/DD NRR/DSS/D NRR/DORL/D NRR/DORL/LLPB/PM NAME GSuber JDonoghue BPham NOtto DATE 04/18/2022 04/25/2022 04/26/2022 04/26/2022 OFFICIAL RECORD COPY